Is bimekizumab effective for patients who have failed an IL-17 blocker?

Featuring April Armstrong, MD, MPH | Co-Director |

Chief, Division of Dermatology
David Geffen School of Medicine at UCLA
Los Angeles, CA

| Published January 01, 2024

Loading...

Related CME

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved